Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Coherus Oncology Inc (CHRS)

Coherus Oncology Inc (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Coherus Oncology Inc 333 TWIN DOLPHIN DRIVE SUITE 600 REDWOOD CITY CA 94065 USA

www.coherus.com Employees: 306 P: 650-649-3530

Sector:

Medical

Description:

Coherus is a fully integrated commercial-stage innovative oncology company. Coherus, formerly known as Coherus BioSciences Inc., is based in REDWOOD CITY, Calif.

Key Statistics

Overview:

Market Capitalization, $K 200,646
Enterprise Value, $K 111,356
Shares Outstanding, K 120,871
Float, K 111,105
% Float 91.92%
Short Interest, K 29,855
Short Float 24.70%
Days to Cover 29.33
Short Volume Ratio 0.23
% of Insider Shareholders 8.08%
% of Institutional Shareholders 72.82%

Financials:

Annual Sales, $ 266,960 K
Annual Net Income, $ 28,510 K
Last Quarter Sales, $ 11,570 K
Last Quarter Net Income, $ -35,530 K
EBIT, $ -177,510 K
EBITDA, $ -172,230 K

Growth:

1-Year Return 12.68%
3-Year Return -82.26%
5-Year Return -91.27%
5-Year Revenue Growth -25.03%
5-Year Earnings Growth -79.67%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.33 on 11/06/25
Next Earnings Date 03/09/26
Earnings Per Share ttm -1.62
EPS Growth vs. Prev Qtr 2.56%
EPS Growth vs. Prev Year -322.22%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payable Date 01/16/95
Dividend Payout Ratio 0.00%

CHRS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -42.23%
Profit Margin % 10.68%
Debt/Equity 0.42
Price/Sales 0.67
Price/Cash Flow 5.49
Price/Book 2.12
Book Value/Share 0.76
Interest Coverage 2.05
60-Month Beta 0.96
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar